Capstone Investment Advisors »

Biosante Pharmaceuticals shares owned by Capstone Investment Advisors

Quarter-by-quarter ownership of Biosante Pharmaceuticals (ANIP) shares owned by Capstone Investment Advisors from 13F filings

Historical chart of Capstone Investment Advisors investment in Biosante Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Biosante Pharmaceuticals held by Capstone Investment Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Biosante Pharmaceuticals by Capstone Investment Advisors

Quarter filed Position value Share count Share price at filing
2025-12-31 $784k 9.9k 78.94